Projects per year
Search results
-
Active
GLAM study - Genomic Liquid biopsy Analysis for Multiple myeloma
Spencer, A. (Primary Chief Investigator (PCI)), Mithraprabhu, S. (Chief Investigator (CI)), Reynolds, J. (Chief Investigator (CI)), Wood, E. (Chief Investigator (CI)), Wellard, C. (Chief Investigator (CI)), Bingham, N. (Chief Investigator (CI)), Wong, D. (Chief Investigator (CI)), Irving, A. (Chief Investigator (CI)), Wright, T. (Chief Investigator (CI)), Ho, P. J. (Chief Investigator (CI)) & McCaughan, G. (Chief Investigator (CI))
1/08/24 → 31/07/28
Project: Research
-
Establishing blood-based liquid biopsies for early detection of high-risk multiple myeloma
Bingham, N., Mithraprabhu, S., Spencer, A. & Reynolds, J.
1/07/24 → 1/07/25
Project: Research
-
Defining the circulating genome of high-risk plasma cell disorders to improve risk stratification and clinical management
Mithraprabhu, S. (Primary Chief Investigator (PCI)), Khong, T. (Chief Investigator (CI)), Reynolds, J. (Chief Investigator (CI)), Murray, D. (Chief Investigator (CI)), Shah, J. (Chief Investigator (CI)), Wellard, C. (Chief Investigator (CI)), Spencer, A. (Associate Investigator (AI)), Ross, J. (Associate Investigator (AI)), Perkins, A. (Associate Investigator (AI)), Marks, A. (Associate Investigator (AI)), Beer, H. (Associate Investigator (AI)) & Henderson, M. (Associate Investigator (AI))
1/04/24 → 31/12/26
Project: Research
-
AAT-APP Trial: A RCT of alcohol approach-avoidance training to reduce heavy drinking in people with alcohol use disorders
Manning, V. (Primary Chief Investigator (PCI)), Verdejo-Garcia, A. (Chief Investigator (CI)), Lubman, D. (Chief Investigator (CI)), Staiger, P. K. (Chief Investigator (CI)), Garfield, J. (Chief Investigator (CI)), Reynolds, J. (Chief Investigator (CI)), de New, S. (Chief Investigator (CI)), Wiers, R. (Chief Investigator (CI)) & Roxburgh, A. (Associate Investigator (AI))
1/01/23 → 30/06/26
Project: Research
-
More efficient delivery of high-cost standard-of-care therapies in relapsed multiple myeloma using real-time feedback of patient-reported outcome measures: the MY-PROMPT-2 trial
Spencer, A. (Primary Chief Investigator (PCI)), Rutherford, C. (Chief Investigator (CI)), Reynolds, J. (Chief Investigator (CI)), Ho, P. J. (Chief Investigator (CI)), McQuilten, Z. (Chief Investigator (CI)), Moore, E. (Chief Investigator (CI)), King, T. (Chief Investigator (CI)), Wood, E. (Chief Investigator (CI)), Harrison, S. J. (Chief Investigator (CI)) & Irving, A. (Chief Investigator (CI))
Department of Health and Aged Care (Australia)
1/02/22 → 31/01/27
Project: Research
-
INTERCEPT (Investigating Novel Therapy to target Early Relapse and Clonal Evolution as Pre-emptive Therapy in AML): a multi-arm, precision-based, recursive, platform trial
Wei, A. (Primary Chief Investigator (PCI)), DiNardo, C. (Chief Investigator (CI)), Roberts, A. W. (Chief Investigator (CI)), Daver, N. (Chief Investigator (CI)), Reynolds, J. (Chief Investigator (CI)), Blombery, P. (Chief Investigator (CI)), Marlton, P. (Chief Investigator (CI)) & Curtis, D. (Chief Investigator (CI))
1/07/21 → 30/06/26
Project: Research
-
Preventing infections in patients with blood cancer through evidence-based use of immunoglobulin or alternatives: The RATIONALISE trial
Wood, E. (Primary Chief Investigator (PCI)), McQuilten, Z. (Chief Investigator (CI)), Morrissey, O. (Chief Investigator (CI)), Trotman, J. (Chief Investigator (CI)), Spencer, A. (Chief Investigator (CI)), Opat, S. (Chief Investigator (CI)), Fanning, L. (Chief Investigator (CI)), Reynolds, J. (Chief Investigator (CI)), Paterson, D. L. (Chief Investigator (CI)) & Mulligan, S. P. (Chief Investigator (CI))
1/07/21 → 30/06/26
Project: Research
-
An ALLG single arm phase II study to evaluate the efficacy of asciminib in newly diagnosed patients with chronic phase chronic myeloid leukaemia
Reynolds, J. (Primary Chief Investigator (PCI))
1/12/20 → 1/12/25
Project: Research
-
Frailty stratified, randomised controlled Bayesian adaptive trial of bortezomib versus lenalidomide in transplant-ineligible myeloma – the FRAIL-M study
Spencer, A. (Primary Chief Investigator (PCI)), McQuilten, Z. (Chief Investigator (CI)), Wood, E. (Chief Investigator (CI)), Reynolds, J. (Chief Investigator (CI)), Quach, H. (Chief Investigator (CI)), De Abreu Lourenco, R. (Chief Investigator (CI)), King, M. (Chief Investigator (CI)), Mollee, P. N. (Chief Investigator (CI)), Hubbard, R. E. (Chief Investigator (CI)) & Le, K. (Chief Investigator (CI))
Department of Health and Aged Care (Australia)
1/12/20 → 30/09/25
Project: Research
-
Precision Medicine for Chronic Myelomonocytic Leukaemia: Phase II Trial Studying the Efficacy of Lenzilumab or High Dose Ascorbate plus Azacitidine Based on Molecular Profiling Compared to Risk-matched Historical Cohort.
Hughes, T. P. (Primary Chief Investigator (PCI)), Hiwase, D. K. (Chief Investigator (CI)), Ross, D. M. (Chief Investigator (CI)) & Reynolds, J. (Chief Investigator (CI))
1/06/20 → 31/05/25
Project: Research
-
Addressing Australia’s national transfusion research priorities
Wood, E. (Primary Chief Investigator (PCI)), McQuilten, Z. (Chief Investigator (CI)), Cameron, P. (Chief Investigator (CI)), Cooper, J. (Chief Investigator (CI)), Reade, M. (Chief Investigator (CI)), Higgins, L. (Chief Investigator (CI)), Trotman, J. (Chief Investigator (CI)), Stanworth, S. J. (Chief Investigator (CI)), Bielby, L. (Chief Investigator (CI)), Coiera, E. (Associate Investigator (AI)), Reynolds, J. (Associate Investigator (AI)), Mo, A. G. Y. (Associate Investigator (AI)), Flint, A. (Associate Investigator (AI)), Sanderson, B. J. (Associate Investigator (AI)), Sparrow, R. (Associate Investigator (AI)), Harris, A. (Associate Investigator (AI)) & French, C. J. (Associate Investigator (AI))
1/01/20 → 31/12/25
Project: Research